We found that the RBL2/E2F-WNT axis regulates the stem cell-like characteristics of CSCs in pancreatic cancer and breast cancer including self-renewal and expression of CSC markers, chemoresistance and invasive capacity. Here, RBL2 is linked to breast cancer.